Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients

被引:33
作者
Qi, Xingshun [1 ]
Han, Guohong [2 ]
Ye, Chun [3 ]
Zhang, Yongguo [1 ]
Dai, Junna [1 ]
Peng, Ying [1 ]
Deng, Han [1 ]
Li, Jing [1 ]
Hou, Feifei [1 ]
Ning, Zheng [1 ]
Zhao, Jiancheng [1 ]
Zhang, Xintong [1 ]
Wang, Ran [1 ]
Guo, Xiaozhong [1 ]
机构
[1] Gen Hosp Shenyang Mil Area, Dept Gastroenterol, Liver Cirrhosis Grp, Shenyang, Liaoning, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian, Shaanxi, Peoples R China
[3] Gen Hosp Shenyang Mil Area, Dept Gen Surg, Shenyang, Liaoning, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2016年 / 22卷
基金
中国国家自然科学基金;
关键词
Liver Cirrhosis; Portal Vein; Venous Thrombosis; CHRONIC HEPATITIS-C; BUDD-CHIARI-SYNDROME; FACTOR-V-LEIDEN; VEIN-THROMBOSIS; LAPAROSCOPIC SPLENECTOMY; VARICEAL HEMORRHAGE; ESOPHAGEAL-VARICES; ACCURATE MARKER; HYPERTENSION; MANAGEMENT;
D O I
10.12659/MSM.898866
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Portal venous system thrombosis (PVST) is a life-threatening complication of liver cirrhosis. We conducted a retrospective study to comprehensively analyze the prevalence and risk factors of PVST in liver cirrhosis. Material/Methods: All cirrhotic patients without malignancy admitted between June 2012 and December 2013 were eligible if they underwent contrast-enhanced CT or MRI scans. Independent predictors of PVST in liver cirrhosis were calculated in multivariate analyses. Subgroup analyses were performed according to the severity of PVST (any PVST, main portal vein [MPV] thrombosis >50%, and clinically significant PVST) and splenectomy. Odds ratios (ORs) and 95% confidence intervals (CIs) were reported. Results: Overall, 113 cirrhotic patients were enrolled. The prevalence of PVST was 16.8% (19/113). Splenectomy (any PVST: OR=11.494, 95%CI=2.152-61.395; MPV thrombosis >50%: OR=29.987, 95%CI=3.247-276.949; clinically significant PVST: OR=40.415, 95%CI=3.895-419.295) and higher hemoglobin (any PVST: OR=0.974, 95%CI=0.953-0.996; MPV thrombosis >50%: OR=0.936, 95%CI=0.895-0.980; clinically significant PVST: OR=0.935, 95%CI=0.891-0.982) were the independent predictors of PVST. The prevalence of PVST was 13.3% (14/105) after excluding splenectomy. Higher hemoglobin was the only independent predictor of MPV thrombosis >50% (OR=0.952, 95%CI=0.909-0.997). No independent predictors of any PVST or clinically significant PVST were identified in multivariate analyses. Additionally, PVST patients who underwent splenectomy had a significantly higher proportion of clinically significant PVST but lower MELD score than those who did not undergo splenectomy. In all analyses, the in-hospital mortality was not significantly different between cirrhotic patient with and without PVST. Conclusions: Splenectomy may increase by at least 10-fold the risk of PVST in liver cirrhosis independent of severity of liver dysfunction.
引用
收藏
页码:2528 / 2550
页数:23
相关论文
共 48 条
[1]   Incidence of Deep Vein Thrombosis and Thrombosis of the Portal Mesenteric Axis After Laparoscopic Sleeve Gastrectomy [J].
Alsina, Ena ;
Ruiz-Tovar, Jaime ;
Remedios Alpera, Maria ;
Gregorio Ruiz-Garcia, Jose ;
Enrique Lopez-Perez, Manuel ;
Francisco Ramon-Sanchez, Jose ;
Ardoy, Francisco .
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2014, 24 (09) :601-605
[2]   Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis [J].
Amitrano, Lucio ;
Guardascione, Maria Anna ;
Menchise, Antonella ;
Martino, Rossana ;
Scaglione, Mariano ;
Giovine, Sabrina ;
Romano, Luigia ;
Balzano, Antonio .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (06) :448-451
[3]  
[Anonymous], 2014, GASTROENTEROLOGY RES
[4]   Nontumoral portal vein thrombosis in patients awaiting liver transplantation [J].
Chen, Hui ;
Turon, Fanny ;
Hernandez-Gea, Virginia ;
Fuster, Josep ;
Garcia-Criado, Angeles ;
Barrufet, Marta ;
Darnell, Anna ;
Fondevila, Constantino ;
Carlos Garcia-Valdecasas, Juan ;
Carlos Garcia-Pagan, Juan .
LIVER TRANSPLANTATION, 2016, 22 (03) :352-365
[5]   Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis [J].
Chen, Hui ;
Liu, Lei ;
Qi, Xingshun ;
He, Chuangye ;
Wu, Feifei ;
Fan, Daiming ;
Han, Guohong .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (01) :82-89
[6]   Laparoscopic splenectomy with or without devascularization of the stomach for liver cirrhosis and portal hypertension: a systematic review [J].
Chen, Xiao-Dong ;
He, Fu-Qian ;
Yang, Lie ;
Yu, Yong-Yang ;
Zhou, Zong-Guang .
ANZ JOURNAL OF SURGERY, 2013, 83 (03) :122-128
[7]   Esophagogastric variceal bleeding in cirrhotic portal hypertension: consensus on prevention and management (2008) [J].
Cheng Liu-fang ;
Jia Ji-dong ;
Xu Xiao-yuan ;
Linghu En-qiang ;
Liu Yu-lan ;
Leng Xi-sheng ;
Wang Mao-qiang .
CHINESE MEDICAL JOURNAL, 2009, 122 (07) :766-775
[8]   Therapeutic Effects of Laparoscopic Splenectomy and Esophagogastric Devascularization on Liver Cirrhosis and Portal Hypertension in 204 Cases [J].
Cheng, Zhe ;
Li, Jian-wei ;
Chen, Jian ;
Fan, Yu-dong ;
Guo, Peng ;
Zheng, Shu-guo .
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2014, 24 (09) :612-616
[9]   King's Score: an accurate marker of cirrhosis in chronic hepatitis C [J].
Cross, Timothy J. S. ;
Rizzi, Paolo ;
Berry, Philip A. ;
Bruce, Matthew ;
Portmann, Bernard ;
Harrison, Phillip M. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (07) :730-738
[10]   Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators [J].
D'Amico, G ;
De Franchis, R .
HEPATOLOGY, 2003, 38 (03) :599-612